Solar panels stop working when the sky goes dark. That simple fact has pushed energy researchers into a stubborn problem: how ...

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

State-backed CDP Equity to have a stake in combined entity Deal comes after Chiesi's $1.9 billion buyout of U.S. KalVista Angelini aims to create global player in rare disease drugs ROME/MILAN, May 7 ...

SANTA CRUZ — A small group of music fans and Santa Cruz City Council candidates have created a petition in hopes of saving the Catalyst Club in downtown Santa Cruz. The building at 1011 Pacific Ave.

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.

Artificial intelligence (AI) is transforming the way scientists discover and design new materials. In a specially invited review published in Angewandte Chemie International Edition, Tohoku University ...

Revised terms due to delayed projects, lower profits JMAT plans to return 1 billion stg to shareholders post-sale completion Jefferies analysts note revised terms better than potential deal ...

Researchers have found that manganese, an abundant and inexpensive metal, can be used to efficiently convert carbon dioxide into formate, a potential hydrogen source for fuel cells. The key was a ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. The Tomb Raider franchise is one of the most prolific and ...

Grammarly has secured a $1 billion commitment from General Catalyst. The 16-year-old writing assistant startup will use the new funds for its sales and marketing efforts, freeing up existing capital ...